Nektar Therapeutics Stock Technical Analysis
NKTR Stock | USD 0.93 0.04 4.49% |
As of the 28th of March, Nektar Therapeutics secures the Downside Deviation of 4.19, risk adjusted performance of 0.1166, and Mean Deviation of 4.49. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nektar Therapeutics, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Nektar Therapeutics, which can be compared to its peers in the industry. Please verify Nektar Therapeutics coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Nektar Therapeutics is priced some-what accurately, providing market reflects its recent price of 0.93 per share. Given that Nektar Therapeutics is a hitting penny stock territory we strongly suggest to closely look at its total risk alpha.
Nektar Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Nektar, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NektarNektar |
Nektar Therapeutics Analyst Consensus
Target Price | Advice | # of Analysts | |
2.88 | Hold | 4 | Odds |
Most Nektar analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Nektar stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Nektar Therapeutics, talking to its executives and customers, or listening to Nektar conference calls.
Nektar Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Nektar Therapeutics Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Nektar Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Nektar Therapeutics Trend Analysis
Use this graph to draw trend lines for Nektar Therapeutics. You can use it to identify possible trend reversals for Nektar Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Nektar Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Nektar Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Nektar Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.01 , which means Nektar Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 2.25, which is the sum of squared deviations for the predicted Nektar Therapeutics price change compared to its average price change.About Nektar Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Nektar Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Nektar Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Nektar Therapeutics price pattern first instead of the macroeconomic environment surrounding Nektar Therapeutics. By analyzing Nektar Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Nektar Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Nektar Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
2023 | 2024 (projected) | Dividend Yield | 0.001039 | 9.87E-4 | Price To Sales Ratio | 1.19 | 1.13 |
Nektar Therapeutics March 28, 2024 Technical Indicators
Most technical analysis of Nektar help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Nektar from various momentum indicators to cycle indicators. When you analyze Nektar charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.1166 | |||
Market Risk Adjusted Performance | 4.09 | |||
Mean Deviation | 4.49 | |||
Semi Deviation | 3.23 | |||
Downside Deviation | 4.19 | |||
Coefficient Of Variation | 516.7 | |||
Standard Deviation | 5.97 | |||
Variance | 35.68 | |||
Information Ratio | 0.1711 | |||
Jensen Alpha | 1.11 | |||
Total Risk Alpha | (0.19) | |||
Sortino Ratio | 0.2437 | |||
Treynor Ratio | 4.08 | |||
Maximum Drawdown | 30.22 | |||
Value At Risk | (5.77) | |||
Potential Upside | 12.24 | |||
Downside Variance | 17.58 | |||
Semi Variance | 10.46 | |||
Expected Short fall | (6.86) | |||
Skewness | 1.2 | |||
Kurtosis | 1.55 |
Nektar Therapeutics March 28, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Nektar stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 111,996 | ||
Daily Balance Of Power | 0.50 | ||
Rate Of Daily Change | 1.04 | ||
Day Median Price | 0.90 | ||
Day Typical Price | 0.91 | ||
Price Action Indicator | 0.05 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nektar Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Nektar Stock, please use our How to Invest in Nektar Therapeutics guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Nektar Stock analysis
When running Nektar Therapeutics' price analysis, check to measure Nektar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nektar Therapeutics is operating at the current time. Most of Nektar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nektar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nektar Therapeutics' price. Additionally, you may evaluate how the addition of Nektar Therapeutics to your portfolios can decrease your overall portfolio volatility.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Nektar Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nektar Therapeutics. If investors know Nektar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nektar Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.45) | Revenue Per Share 0.474 | Quarterly Revenue Growth 0.085 | Return On Assets (0.15) | Return On Equity (1.11) |
The market value of Nektar Therapeutics is measured differently than its book value, which is the value of Nektar that is recorded on the company's balance sheet. Investors also form their own opinion of Nektar Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Nektar Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nektar Therapeutics' market value can be influenced by many factors that don't directly affect Nektar Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nektar Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nektar Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nektar Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.